Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 76
12
Diseases
81
Unique genes
0.110
Avg. similarity score
Cachexia
Most-connected disease (7 links)
Disease
Searched: Oral submucous fibrosis
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Oral submucous fibrosis
Cachexia
Alcoholic hepatitis
Autoimmune uveitis
Esotropia
Angina pectoris
Hepatolenticular degeneration
Delirium
ALG11-congenital disorder of glycosylation
Chondromalacia
X-linked ichthyosis with steryl-sulfatase deficiency
lymphoproliferative syndrome 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cachexia | 7 | 7 | 12 |
| Alcoholic hepatitis | 6 | 6 | 5 |
| Autoimmune uveitis | 5 | 5 | 1 |
| Esotropia | 5 | 5 | 10 |
| Angina pectoris | 4 | 4 | 12 |
| Hepatolenticular degeneration | 4 | 4 | 27 |
| Oral submucous fibrosis | 4 | 4 | 20 |
| Delirium | 3 | 3 | 10 |
| ALG11-congenital disorder of glycosylation | 1 | 1 | 1 |
| Chondromalacia | 1 | 1 | 8 |
| X-linked ichthyosis with steryl-sulfatase deficiency | 1 | 1 | 1 |
| lymphoproliferative syndrome 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CXCL8 | 8 / 12 | Alcoholic hepatitis, Angina pectoris, Autoimmune uveitis, Cachexia and 4 more |
| TNF | 6 / 12 | Alcoholic hepatitis, Angina pectoris, Cachexia, Esotropia and 2 more |
| IL6 | 4 / 12 | Cachexia, Delirium, Hepatolenticular degeneration, Oral submucous fibrosis |
| PTGS2 | 3 / 12 | Cachexia, Esotropia, Oral submucous fibrosis |
| ALG11 | 2 / 12 | ALG11-congenital disorder of glycosylation, Hepatolenticular degeneration |
| APOE | 2 / 12 | Delirium, Hepatolenticular degeneration |
| CD27 | 2 / 12 | Cachexia, lymphoproliferative syndrome 2 |
| IGF1 | 2 / 12 | Cachexia, Delirium |
| LOX | 2 / 12 | Hepatolenticular degeneration, Oral submucous fibrosis |
| MMP1 | 2 / 12 | Angina pectoris, Oral submucous fibrosis |
| MMP9 | 2 / 12 | Angina pectoris, Oral submucous fibrosis |
| STS | 2 / 12 | Alcoholic hepatitis, X-linked ichthyosis with steryl-sulfatase deficiency |
| SULT1E1 | 2 / 12 | Alcoholic hepatitis, Chondromalacia |
| TIMP1 | 2 / 12 | Hepatolenticular degeneration, Oral submucous fibrosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interleukin-4 and Interleukin-13 signaling | Reactome | 15 / 108 | 20.6× | 3.72e-16 | 1.47e-13 ✓ sig. |
| Interleukin-10 signaling | Reactome | 10 / 47 | 31.5× | 4.65e-13 | 1.06e-10 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 10 / 125 | 11.9× | 1.04e-8 | 9.51e-7 ✓ sig. |
| Proteoglycans in cancer | KEGG | 12 / 204 | 8.7× | 1.06e-8 | 9.61e-7 ✓ sig. |
| Rheumatoid arthritis | KEGG | 9 / 95 | 14.0× | 1.35e-8 | 1.19e-6 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 12 / 216 | 8.2× | 2.00e-8 | 1.69e-6 ✓ sig. |
| Chagas disease | KEGG | 9 / 103 | 13.0× | 2.75e-8 | 2.24e-6 ✓ sig. |
| Amoebiasis | KEGG | 9 / 103 | 13.0× | 2.75e-8 | 2.24e-6 ✓ sig. |
| Malaria | KEGG | 7 / 50 | 20.8× | 3.86e-8 | 2.99e-6 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 13 / 298 | 6.5× | 8.61e-8 | 6.17e-6 ✓ sig. |
| Inflammatory bowel disease | KEGG | 7 / 66 | 15.7× | 2.76e-7 | 1.70e-5 ✓ sig. |
| Tuberculosis | KEGG | 10 / 181 | 8.2× | 3.51e-7 | 2.10e-5 ✓ sig. |
| Pathways in cancer | KEGG | 15 / 533 | 4.2× | 2.27e-6 | 1.06e-4 ✓ sig. |
| IL-17 signaling pathway | KEGG | 7 / 94 | 11.0× | 3.12e-6 | 1.38e-4 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 7 / 101 | 10.3× | 5.04e-6 | 2.04e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of smooth muscle cell proliferation | GO:0048661 | 9 / 52 | 39.9× | 1.08e-12 | 4.98e-10 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 13 / 248 | 12.1× | 4.88e-11 | 1.53e-8 ✓ sig. |
| response to ethanol | GO:0045471 | 9 / 110 | 18.9× | 1.12e-9 | 2.48e-7 ✓ sig. |
| response to hypoxia | GO:0001666 | 10 / 176 | 13.1× | 4.48e-9 | 8.40e-7 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 15 / 524 | 6.6× | 6.33e-9 | 1.14e-6 ✓ sig. |
| positive regulation of nitric oxide biosynthetic process | GO:0045429 | 6 / 42 | 33.0× | 2.54e-8 | 3.84e-6 ✓ sig. |
| positive regulation of receptor signaling pathway via STAT | GO:1904894 | 4 / 9 | 103× | 4.06e-8 | 5.71e-6 ✓ sig. |
| immune response | GO:0006955 | 14 / 543 | 5.9× | 7.90e-8 | 1.01e-5 ✓ sig. |
| cellular response to UV-A | GO:0071492 | 4 / 11 | 83.9× | 1.06e-7 | 1.29e-5 ✓ sig. |
| positive regulation of vascular associated smooth muscle cell proliferation | GO:1904707 | 6 / 53 | 26.1× | 1.07e-7 | 1.30e-5 ✓ sig. |
| cell surface receptor signaling pathway via STAT | GO:0097696 | 5 / 28 | 41.2× | 1.23e-7 | 1.46e-5 ✓ sig. |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 5 / 33 | 35.0× | 2.91e-7 | 3.06e-5 ✓ sig. |
| synaptic transmission, dopaminergic | GO:0001963 | 4 / 15 | 61.5× | 4.31e-7 | 4.24e-5 ✓ sig. |
| negative regulation of cell population proliferation | GO:0008285 | 12 / 444 | 6.2× | 4.48e-7 | 4.38e-5 ✓ sig. |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 / 17 | 54.3× | 7.47e-7 | 6.68e-5 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hepatolenticular degeneration | Oral submucous fibrosis | 0.116 | 5 | 1.71e-10 | 1.66e-9 ✓ sig. |
| Angina pectoris | Oral submucous fibrosis | 0.138 | 4 | 1.02e-9 | 9.21e-9 ✓ sig. |
| Cachexia | Oral submucous fibrosis | 0.138 | 4 | 1.02e-9 | 9.21e-9 ✓ sig. |
| Cachexia | Delirium | 0.150 | 3 | 4.33e-8 | 3.23e-7 ✓ sig. |
| Cachexia | Esotropia | 0.150 | 3 | 4.33e-8 | 3.23e-7 ✓ sig. |
| Esotropia | Oral submucous fibrosis | 0.107 | 3 | 2.24e-7 | 1.48e-6 ✓ sig. |
| Delirium | Hepatolenticular degeneration | 0.086 | 3 | 5.72e-7 | 3.50e-6 ✓ sig. |
| Cachexia | Hepatolenticular degeneration | 0.081 | 3 | 1.05e-6 | 6.15e-6 ✓ sig. |
| Alcoholic hepatitis | Esotropia | 0.143 | 2 | 3.79e-6 | 2.01e-5 ✓ sig. |
| Alcoholic hepatitis | Angina pectoris | 0.125 | 2 | 5.56e-6 | 2.87e-5 ✓ sig. |
| Alcoholic hepatitis | Cachexia | 0.125 | 2 | 5.56e-6 | 2.87e-5 ✓ sig. |
| Angina pectoris | Esotropia | 0.095 | 2 | 2.50e-5 | 1.17e-4 ✓ sig. |
| Alcoholic hepatitis | X-linked ichthyosis with steryl-sulfatase deficiency | 0.167 | 1 | 3.25e-4 | 7.71e-4 ✓ sig. |
| Alcoholic hepatitis | Autoimmune uveitis | 0.167 | 1 | 3.25e-4 | 7.71e-4 ✓ sig. |
| Autoimmune uveitis | Esotropia | 0.091 | 1 | 6.49e-4 | 1.24e-3 ✓ sig. |
| Autoimmune uveitis | Delirium | 0.091 | 1 | 6.49e-4 | 1.24e-3 ✓ sig. |
| Cachexia | lymphoproliferative syndrome 2 | 0.077 | 1 | 7.79e-4 | 1.41e-3 ✓ sig. |
| Autoimmune uveitis | Cachexia | 0.077 | 1 | 7.79e-4 | 1.41e-3 ✓ sig. |
| Angina pectoris | Autoimmune uveitis | 0.077 | 1 | 7.79e-4 | 1.41e-3 ✓ sig. |
| ALG11-congenital disorder of glycosylation | Hepatolenticular degeneration | 0.036 | 1 | 1.75e-3 | 2.61e-3 ✓ sig. |
| Alcoholic hepatitis | Chondromalacia | 0.077 | 1 | 2.60e-3 | 3.51e-3 ✓ sig. |